Pyridoxine, folate and cobalamin for migraine: A systematic review
Date
2020Language
en
Sujet
Résumé
There is a possible relationship between migraine and hypercoagulability inducing factors, such as hyperhomocysteinemia. In this context, homocysteine (Hcy)-lowering vitamins (B6-folate-B12) may prove beneficial in the management—prophylaxis of migraine. We performed a systematic literature search in order to retrieve studies assessing the supplementation of B6, folate and B12 (alone or as adjunctive therapies) to migraine patients, as well as patients suffering from other primary headache disorders. MEDLINE, EMBASE, CENTRAL, Google Scholar, trial registries and OpenGrey were searched. Twelve relevant articles were retrieved. The management of acute migraine attacks with Hcy-lowering vitamins has not provided promising results (one randomized controlled trial—RCT—and one prospective uncontrolled trial). On the contrary, significant benefits were registered for the use of B6 alone, in combination with folate and in combination with folate and B12 in the prophylaxis of migraine with aura (MA) in adults compared to placebo (five RCTs, only one did not obtain significant results). Folate supplementation alone was not more efficacious than placebo (one RCT). Limited data for the prophylaxis of migraine without aura (MO) in children (two prospective uncontrolled trials) and adults (two prospective uncontrolled trials involving both MA and MO participants) impede the extraction of safe conclusions. An overall attractive safety profile was exhibited with gastrointestinal adverse events being the most common. Overall, a potential beneficial effect regarding the administration of B6, folate and/or B12 in the prophylaxis of MA in adults was indicated. Additional high-quality RCTs that will investigate MO in adults as well as MO and MA in children are warranted. © 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Collections
Related items
Showing items related by title, author, creator and subject.
-
Serum Homocysteine, Pyridoxine, Folate, and Vitamin B12 Levels in Migraine: Systematic Review and Meta-Analysis
Liampas I., Siokas V., Mentis A.-F.A., Aloizou A.-M., Dastamani M., Tsouris Z., Aslanidou P., Brotis A., Dardiotis E. (2020)Background: Migraine, especially migraine with aura (MA), has been linked to increased risk for ischemic cerebrovascular disease. The possible role of elevated serum homocysteine (Hcy, a cause of thrombophilia) in migraine ... -
Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)
Sacco S., Merki-Feld G.S., Ægidius K.L., Bitzer J., Canonico M., Kurth T., Lampl C., Lidegaard Ø., Anne MacGregor E., MaassenVanDenBrink A., Mitsikostas D.-D., Nappi R.E., Ntaios G., Sandset P.M., Martelletti P., on behalf of the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC) (2017)Several data indicate that migraine, especially migraine with aura, is associated with an increased risk of ischemic stroke and other vascular events. Of concern is whether the risk of ischemic stroke in migraineurs is ... -
Serum lipid abnormalities in migraine: A meta-analysis of observational studies
Liampas I., Mylonas K.S., Brotis A., Dervenis P., Siokas V., Mentis A.-F.A., Dastamani M., Aloizou A.-M., Tsouris Z., Aslanidou P., Bakoyiannis C., Dardiotis E. (2021)Background: The association of migraine with vascular comorbidities is long-established. The contribution of the “traditional” cardiovascular risk factors to this connection remains unclear. Objective: To determine-quantify ...